212 related articles for article (PubMed ID: 23706017)
21. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
22. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
23. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.
Leplina O; Kurochkina Y; Tikhonova M; Shevela E; Ostanin A; Chernykh E
Inflammopharmacology; 2020 Feb; 28(1):311-319. PubMed ID: 31552546
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes.
la Sala A; Sebastiani S; Ferrari D; Di Virgilio F; Idzko M; Norgauer J; Girolomoni G
Blood; 2002 Mar; 99(5):1715-22. PubMed ID: 11861288
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response.
García-González PA; Schinnerling K; Sepúlveda-Gutiérrez A; Maggi J; Mehdi AM; Nel HJ; Pesce B; Larrondo ML; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2017; 8():1350. PubMed ID: 29109727
[TBL] [Abstract][Full Text] [Related]
27. Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.
Zhang W; Lim SM; Hwang J; Ramalingam S; Kim M; Jin JO
Cancer Immunol Immunother; 2021 Mar; 70(3):689-700. PubMed ID: 32902663
[TBL] [Abstract][Full Text] [Related]
28. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.
Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J
J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918
[TBL] [Abstract][Full Text] [Related]
29. Distinct effect of CD40 and TNF-signaling on the chemokine/chemokine receptor expression and function of the human monocyte-derived dendritic cells.
Xia Y; Dai J; Lu P; Huang Y; Zhu Y; Zhang X
Cell Mol Immunol; 2008 Apr; 5(2):121-31. PubMed ID: 18445342
[TBL] [Abstract][Full Text] [Related]
30. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.
Ren Y; Yang Y; Yang J; Xie R; Fan H
Int Immunopharmacol; 2014 Jul; 21(1):247-54. PubMed ID: 24836681
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
[TBL] [Abstract][Full Text] [Related]
32. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.
Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A
Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
34. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
35. High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells.
Jia S; Kim J; Esser-Kahn AP; Deak P
Front Med (Lausanne); 2023; 10():1298424. PubMed ID: 38249971
[TBL] [Abstract][Full Text] [Related]
36. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.
Ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; van Ham SM
Vaccine; 2007 Oct; 25(41):7145-52. PubMed ID: 17719152
[TBL] [Abstract][Full Text] [Related]
37. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.
Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS
Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531
[TBL] [Abstract][Full Text] [Related]
38. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
39. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.
Dixon KO; van der Kooij SW; Vignali DA; van Kooten C
Eur J Immunol; 2015 Jun; 45(6):1736-47. PubMed ID: 25820702
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.
Scandella E; Men Y; Gillessen S; Förster R; Groettrup M
Blood; 2002 Aug; 100(4):1354-61. PubMed ID: 12149218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
